Papilocare Vaginal Gel 21 canulas of 5 ml

Product Information

Persoane HPV pozitive cu leziuni (tratamentul leziunilor și prevenirea altora noi) - recomandat - Papilocare® Gel pentru zona genitală Hyaluronic acid niosomes): основното им свойство е повърхностно овлажняване на тъканите, придавайки им еластичност. Restauración del equilibrio del microbioma: Papilocare contribuye a restaurar el equilibrio natural del microbioma vaginal, promoviendo un entorno saludable y previniendo infecciones. Avertisment: A nu se utiliza la persoane cu hipersensibilitate cunoscuta la oricare dintre ingredientele sale. Daca dupa aplicare simtiti disconfort, intrerupeti utilizarea si adresati-va medicului. Daca sunteti gravida, adresati-va medicului inainte de utilizare. Pastrati produsul intr-un loc racoros si uscat. Nu lasati la indemana copiilor.

O imbunatatire a procesului de vindecare atunci cand este utilizat ca si coadjuvant in tratamentul leziunilor intraepiteliale cauzate de HPV la nivelul mucoasei cervico-vaginale.Aplicati o canula cu doza unica in zona vaginala, de preferinta inainte de culcare. Apasati recipientul pentru a goli continutul acestuia si indepartati-l usor, fara clatire. The percentage of patients with normal Pap smear and concordant colposcopy 3 and 6 months after receiving treatment (78.0% and 84.9%) was significantly higher than without treatment (54.8% and 64.5%), especially in high-risk HPV patients (79.5% and 87.8% vs 52.0% and 56.0%). At 6-month visit, overall HPV clearance was achieved by a greater number of patients receiving treatment (59.6%) compared with those without treatment (41.9%), especially high-risk HPV ones (62.5% vs 40.0%). The cervical re-epithelization score was significantly higher with treatment (mean = 4.5) than without (mean = 4.1). Compared with baseline, perceived stress decreased in the treatment group (from 21.1 to 19.0) and increased in the control group (from 17.7 to 20.7). A total of 7 possible or probable treatment-related adverse events were reported, most of them (n = 6) being mild or moderate in severity. Conclusions

Disponibilidad en nuestra farmacia online: Papilocare está disponible para su compra en nuestra farmacia online, ofreciendo comodidad y discreción a nuestros clientes.Obstetrics and Gynaecology Department, Hospital Universitario Infanta Leonor, Av. Gran Vía del Este, 80, 28031 Madrid, Spain. You can use Papilocare® at any time of day, but the gel is more likely to remain in place if you apply it just before bedtime.

Extracto de centella asiática: Este extracto de planta contiene componentes activos que promueven la reparación y regeneración de la piel, ayudando a sanar las lesiones cervicales y vaginales. Approximately 30% of Spanish women younger than 30 years are HPV carriers. 25 The likelihood of HPV infection decreases over time, from 47% between the ages of 15 and 19 years to 12% in women older than 45 years. 26 The HPV is a fundamental factor for the development of cervical cancer. 27 The World Health Organization has recently established the elimination of cervical cancer as a priority medium-term objective. 28 This trial aimed to explore whether treatment with Papilocare provides better results than the conventional watchful waiting strategy in improving low-grade cervical lesions, which are the first step in the natural history of cervical cancer. 29 Clearance of LSILs after a conservative approach is of approximately 59% within 2 years of the diagnosis. Nevertheless, the likelihood of progression of these lesions to a high-grade squamous intraepithelial lesion within 5 years is 12.7%. 30 In addition, treatments for cervical cancer severely compromise the reproductive health of women. In a systematic review of Cochrane, Kyrgiou et al. 31 demonstrated a higher baseline risk for prematurity in women with cervical intraepithelial neoplasia, which increased with excisional and ablative treatments. Therefore, the scenario is conflicting, as choosing an excisional or ablative approach for the treatment of LSILs can result in negative reproductive outcomes, but avoiding treatment and just monitoring the disease results in its progression to high-grade lesions in 12 of 100 women. The current recommendation in Spain also includes monitoring the disease. 32, 33 However, based on the results of this present study, a novel strategy involving Papilocare has become available. The results of this treatment in the repair of low-grade lesions have demonstrated to significantly exceed those obtained with the watchful waiting approach (8 in 10 women achieved a normalization in their lesions). Sudedamosios dalys, leidžiančios susidaryti mukoadheziniam geliui ant gimdos kaklelio ir gimdos kaklelio gleivinės

Castellsagué X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX et al. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study. J Med Virol. 2012;84:947-56. The purpose of the present study was to evaluate the efficacy of Papilocare in repairing cervical mucosa lesions in HPV-positive women with low-grade Pap smear alterations and consistent colposcopy observations. METHODS Study Design and Patients Papilocare Gel Vaginal poate fi utilizat pentru a combate uscăciunea și disconfortul asociat mucoasei cervico-vaginale. Gelul hidratează și menține nivelul optim de umiditate, contribuind astfel la restabilirea confortului și sănătății vaginale.